Advertisement

Topics

Signostics Limited Company Profile

05:36 EST 13th December 2018 | BioPortfolio


News Articles [36 Associated News Articles listed on BioPortfolio]

EchoNous Announces Biomedical Engineers and Managers Receive Hands-On Preview of New Multi-Function, Vascular and Bladder Nursing Platform at AAMI 2018

Pending FDA 510k clearance, new vein finding tool will enable first ever multi-function nursing platform alongside AI-driven bladder tool EchoNous, a developer of intel...

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [89 Associated Companies listed on BioPortfolio]

Signostics Limited

Signostics Inc.

Signostics is a leader in handheld ultrasound devices and bladder scanners. Products include the SignosRT ultrasound system and the SignosRT Bladder, both ultra-portable, affordab...

Signostics Ltd.

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

More Information about "Signostics Limited" on BioPortfolio

We have published hundreds of Signostics Limited news stories on BioPortfolio along with dozens of Signostics Limited Clinical Trials and PubMed Articles about Signostics Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Signostics Limited Companies in our database. You can also find out about relevant Signostics Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record